Insulin receptor: What role in breast cancer?

Trends in Endocrinology and Metabolism

Volumn 8, Issue 8, 1997, Pages 306-312

  Papa, Vincenzo ^a,b   Costantino, Angela ^a   Belfiore, Antonino ^a  

^a UNIVERSITY OF CATANIA   (Italy)

^b Ospedale Garibaldi   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN RECEPTOR;

BREAST CARCINOGENESIS; BREAST CARCINOMA; CANCER GROWTH; CELL PROLIFERATION; GROWTH STIMULATION; HORMONE ACTION; HUMAN; HYPERINSULINISM; INSULIN RESISTANCE; PRIORITY JOURNAL; RECEPTOR DENSITY; REVIEW;

EID: 0030657643     PISSN: 10432760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1043-2760(97)00114-8     Document Type: Review

References (72)

1. Barnes-Josiah D, Potter JD, Sellers TA, Himes JH: 1995. Early body size and subsequent weight gain as predictors of breast cancer incidence (Iowa, USA). Cancer Causes Control 6:112-118.
2. Baserga R: 1995. The insulin-like growth factor-I receptor: a key to tumor growth. Cancer Res 55:249-252.
3. Belfiore A, Costantino A, Frasca F, et al.: 1996. Overexpression of membrane glycoprotein PC-1 in MDA-MB 231 breast cancer cells is associated with inhibition of insulin receptor tyrosine kinase activity. Mol Endocrinol 10:1318-1326.
4. Belli S, van Driel IR, Goding JW: 1993. Identification and characterization of a soluble form of the plasma cell membrane glycoprotein PC-1. J Biochem 217:421-428.
5. Benson EA, Holdaway IM: 1982. Regulation of insulin binding to human mammary carcinoma. Cancer Res 42:1137-1141.
6. Bonneterre J, Peyrat JP, Beuscart R, Demaille A: 1990. Prognostic significance of insulin-like growth factor-I receptors in human breast cancer. Cancer Res 50:6931-6935.
7. Bruning PF, Bonfrer JM, van Noord PA, Hart AA, de Jong Bakker M, Nooijen WJ: 1992. Insulin resistance and breast cancer risk. Int J Cancer 52:511-516.
8. Cheatam B, Kahn CR: 1995. Insulin action and the insulin signaling network. Endocr Rev 16:117-142.
9. Christofori G, Naik P, Hanahan D: 1994. A second signal supplied by insulin like growth factor II in oncogene induced tumorigenesis. Nature 369:414-418.
10. Cohen ND, Hilf R: 1974. Influence of insulin on growth and metabolism of 7,12 dimethylbenzanthracene-induced mammary tumors. Cancer Res 34:3245-3252.
11. Costantino A, Milazzo G, Giorgino F, et al.: 1993. Insulin-resistant MDA-MB 231 human breast cancer cells contain a tyrosine kinase inhibiting activity. Mol Endocrinol 7:1667-1676.
12. Costantino A, Vinci C, Mineo R, et al.: 1996. Interleukin-1 blocks insulin and insulin-like growth factor-stimulated growth in MCF-7 human breast cancer cells by inhibiting tyrosine kinase activity. Endocrinology 137:4100-4107.
13. Cullen KJ, Yee D, Sly WS, et al: 1990. Insulin-like growth factor receptor expression and function in human breast cancer. Cancer Res 50:48-53.
14. D'Ambrosio C, Keller SR, Morrione A, Lienhard GE, Baserga R, Surmacz E: 1995. Transforming potential of the insulin receptor substrate 1. Cell Growth Differ 6:557-562.
15. Danforth DN, Sgagias MK: 1991. Interleukin 1β blocks estradiol-stimulated growth and down-regulates the estrogen receptor in MCF-7 breast cancer cells in vitro. Cancer Res 5:1488-1493.
16. Dickson RB, Lippman M: 1987. Estrogenic regulation of growth and polypeptide growth factor secretion in human breast cancer. Endocr Rev 8:29-43.
17. Dickson RB, Lippman M: 1995. Growth factors in breast cancer. Endocr Rev 16:559-589.
18. Dickson RB, Gottardis MM, Merlino GT: 1991. Molecular insight into breast cancer from transgenic mouse models. Bioessays 13:591-596.
19. Drejer K: 1992. The bioactivity of insulin analogues from in vitro receptor binding to in vivo glucose uptake. Diabetes Metab Rev 8:259-286.
20. Foekens JA, Portengen H, van Putten WLJ, et al.: 1989. Prognostic value of receptors for insulin-like growth factor-I, somatostatin, and epidermal growth factor in human breast cancer. Cancer Res 49:7002-7009.
21. Folsom AR, Kaye SA, Prineas RJ, Potter JD, Gapstur SM, Wallace RB: 1990. Increased incidence of carcinoma of the breast associated with abdominal adiposity in postmenopausal women. Am J Epidemiol 131: 794-803.
22. Frasca F, Pandini G, Mineo R, et al.: 1997. Insulin/IGF-I hybrid receptors are highly-expressed in human breast cancer and are activated by IGF-I. J Endocrinol Invest 20(Suppl 4):105A.
23. Frittitta L, Vigneri R, Papa V, Goldfine ID, Grasso G, Trischitta V: 1993. Structural and functional studies of insulin receptors in human breast cancer. Breast Cancer Res Treat 25:73-82.
24. Frittitta L, Vigneri R, Stampfer M, Goldfine ID: 1995. Insulin receptor overexpression in 184 B5 human mammary epithelial cells induces a ligand dependent transformed phenotype. J Cell Biochem 57:666-669.
25. German-Lee EL, Janicott M, Lammers R, Ullrich A, Casella S: 1992. Expression of a type I insulin-like growth factor receptor with low affinity for insulin-like growth factor II. Biochem J 281:413-417.
26. Giorgino F, Belfiore A, Milazzo G, et al.: 1991. Overexpression of insulin receptors in fibroblast and ovary cells induces a ligand-mediated transformed phenotype. Mol Endocrinol 5:452-459.
27. Hansen BF, Danielsen GM, Drejer K, et al.: 1996. Sustained signalling from the insulin receptor after stimulation with insulin analogues exhibiting increased mitogenic potency. Biochem J 315:271-279.
28. Henderson IC, Harris JR, Kinne DW, Hellmann S. 1989 Cancer of the breast. In De Vita VT Jr, Hellmann S, Rosenberg SA, eds. Cancer, Principles and Practices in Oncology. Philadelphia, Lippincott, pp 1197-1200.
29. Heuson JC, Legros N, Heimann R: 1972. Influence of insulin administration on growth of the 7,12 dimethylbenzanthracene-induced mammary carcinoma in intact, oophorectomized and hypophysectomized rats. Cancer Res 32:233-238.
30. Hofmann C, Goldfine ID, Whittaker J: 1989. The metabolic and mitogenic effects of both insulin and insulin-like growth factor are enhanced by transfection of insulin receptor into NIH3T3 fibroblasts. J Biol Chem 264:8606-8611.
31. Holdaway IM, Friesen HG: 1977. Hormone binding by human mammary carcinoma. Cancer Res 37:1946-1952.
32. Jonas HA, Cox AJ: 1990. Insulin-like growth factor binding to atypical insulin receptors of a human lymphoid-derived cell line (IM-9). Biochem J 266:737-742.
33. Kasuya J, Paz BI, Maddux BA, Goldfine ID, Hefta SA, Yamaguchi YF: 1993. Characterization of human placental insulin-like growth factor-I/insulin hybrid receptors by protein microsequencing and purification. Biochem J 32:13,531-13,536.
34. Kirschner MA, Samojlik E, Drejka M, Szmal E, Schneider G, Ertel N: 1990. Androgen-estrogen metabolism in women with upper body vs. lower body obesity. J Clin Endocrinol Metab 70:473-479.
35. Klijn JGM, Berns PMJJ, Schmitz PIM, Foekens JA: 1992. The clinical significance of epidermal growth factor receptor (EGFR) in human breast cancer: a review of 5232 patients. Endocr Rev 13:3-17.
36. Le Marchand I, Kolonel IN, Earle ME, Mi MP: 1988. Body size at different periods of life and breast cancer risk. Am J Epidemiol 128:137-152.
37. Le Roith D, Werner H, Beitner-Johnson D, Roberts CT: 1995. Molecular and cellular aspect of the insulin-like growth factor-I receptor. Endocr Rev 16:143-163.
38. Mastick CC, Kato H, Roberts CT Jr, LeRoith D, Saltiel AR: 1994. Insulin and insulin like growth factor-I receptors similarly stimulate deoxyribonucleic acid synthesis despite differences in cellular protein tyrosine phosphorylation. Endocrinology 135:214-222.
39. Mathieu MC, Clark G, Allred C, Vigneri R, Goldfine ID, McGuire WL: 1997. Insulin receptor expression and clinical outcome in node-negative breast cancer. Proc Assoc Am Physicians (in press).
40. McElduff P, Poronnik P, Baxter RC, Williams P: 1988. A comparison of the insulin and insulin-like growth factor receptors from rat brain and liver. Endocrinology 122: 1933-1939.
41. Milazzo G, Giorgino F, Damante, et al.: 1992a. Insulin receptor expression and function in human breast cancer cell lines. Cancer Res 52:3924-3930.
42. Milazzo G, Yip CC, Maddux BA, Vigneri R, Goldfine ID: 1992b. High-affinity insulin binding to an atypical insulin-like growth factor-I receptor in human breast cancer cells. J Clin Invest 89:899-908.
43. Milazzo G, Sciacca L, Papa V, et al.: 1997. ASPB10 Insulin induction of increased mitogenic responses and phenotypic changes in human breast epithelial cells: evidence for enhanced interactions with the insulin-like growth factor-I receptor. Mol Carcinog 18:19-25.
44. Mountjoy KG, Finlay GJ, Holdaway IM: 1987. Abnormal insulin receptor down regulation and dissociation of down regulation from insulin biological action in cultured human tumor cells. Cancer Res 47:6500-6504.
45. Olefsky JM: 1990. The insulin receptor a multifunctional protein. Diabetes 39:1009-1016.
46. Osborne CK, Bolan G, Monaco ME, Lippman ME: 1976. Hormone responsive human breast cancer in long term tissue culture: effect of insulin. Proc Natl Acad Sci USA 73:4536-4540.
47. Osborne CK, Clemmons DR, Arteaga CI: 1990. Regulation of breast cancer growth by insulin-like growth factors. J Steroid Biochem Mol Biol 37:805-809.
48. Paciotti FG, Tamarkin L: 1988. Interleukin-1 directly regulates hormone-dependent human breast cancer cell proliferation in vitro. Mol Endocrinol 2:459-464.
49. Papa V, Belfiore A: 1996. Insulin receptor in human breast cancer: biological and clinical role. J Endocrinol Invest 9:324-333.
50. Papa V, Pezzino V, Costantino A, et al.: 1990. Elevated insulin receptor content in human breast cancer. J Clin Invest 86:1503-1510.
51. Papa V, Gliozzo B. Clark GM, et al.: 1993. Insulin-like growth factor-I receptors are overexpressed and predict a low risk in human breast cancer. Cancer Res 53:3736-3740.
52. Papa V, Milazzo G, Goldfine ID, Waldman FM, Vigneri R: 1997. Sporadic amplification of the insulin receptor gene in human breast cancer. J Endocrinol Invest (in press).
53. Pekonen F, Partanen S, Makinen T, Rutanen EM: 1988. Receptors for the epidermal growth factor and insulin-like growth factor-I and their relation to steroid receptors in human breast cancer. Cancer Res 48: 1343-1347.
54. Peyrat JP, Bonneterre J: 1992. Type I IGF-I receptor in human breast cancer. Breast Cancer Res Treat 22:59-67.
55. Pezzino V, Papa V, Milazzo G, et al.: 1996. Insulin-like growth factor I receptors in breast cancer. Ann NY Acad Sci 784:173-188.
56. Poon B, Dixon D, Ellis L, Roth RA, Rutter WJ, Wang LH: 1991. Molecular basis of the activation of the tumorigenic potential of the Gag-insulin receptor chimeras. Proc Natl Acad Sci USA 88:877-881.
57. Reaven GM: 1988. Role of insulin resistance in human diseases. Diabetes 37:1595-1607.
58. Roth RA, Steele-Perkins G, Hari J, et al.: 1988. Insulin and insulin-like growth factor receptors and responses. Cold Spring Harb Symp Quant Biol 53:537-547
59. Sasaoka T, Ishiki M, Sawa T, et al.: 1996. Comparison of the insulin and insulin-like growth factor I mitogenic intracellular signaling pathways. Endocrinology 137:4427-4434.
60. Shafie SM, Gibson SL, Hilf R: 1977. Effect of insulin and estrogen on hormone binding in R3230AC mammary: adenocarcinoma. Cancer Res 37:4641-4649.
61. Soos MA, Siddle K: 1989. Immunological relationship between receptors for insulin and insulin-like growth factor-I. Biochem J 263:553-563.
62. Soos MA, Whittaker J, Lammers R, Ullrich A, Siddle K: 1990. Receptor for insulin and insulin-like growth factor-I can form hybrid dimers. Biochem J 270:383-390.
63. Soos MA, Field CE, Siddle K: 1993. Purified hybrid insulin/insulin-like growth factor-I receptors bind insulin-like growth factor-I but not insulin with high affinity. Biochem J 290:419-426.
64. Sunderland MC, McGuire WL: 1991. Hormones and breast cancer. Trends Endocrinol Metab 2:72-76.
65. Valentinis B, Porcu PL, Quinn K, Baserga R: 1994. The role of the insulin-like growth factor-I receptor in the transformation by simian virus 40 T antigen. Oncogene 9:825-831.
66. Van der Burg B, Rutterman GR, Blankenstein MA, De Laat SW, van Zoelen EJJ: 1988. Mitogenic stimulation of human breast cancer cells in a growth factor defined mediunrsynergistic action of insulin and estrogen. J Cell Physiol 134:101-108.
67. Vogelstein B, Kinzler K: 1994. Has the breast cancer gene been found? Cell 79:1-3.
68. Wang LH, Lin B, Jong SMJ, et al.: 1987. Activation of transforming potential of the human insulin receptor gene. Proc Natl Acad Sci USA 84:5725-5729.
69. Webster NJG, Resnik JL, Reichart DB, Strauss B, Haas M, Seely BL: 1996. Repression of the insulin receptor promoter by the tumor suppressor gene product p53: a possible mechanism for receptor overexpression. Cancer Res 56:2781-2788.
70. Werner H, Karnieli E, Rauscher III FJ, LeRoith: 1996. Wild-type and mutant p53 differentially regulate transcription of the insulin-like growth factor receptor gene. Proc Natl Acad Sci USA 93:8318-8323.
71. Wong WW, Vijayakumar S, Weichselbaum RR: 1992. Prognostic indicators in node negative early stage breast cancer. Am J Med 92:539-548.
72. Yenush L, Kundra V, White MF, Zetter BR: 1994. Functional domains of the insulin receptor responsible for chemotactic signaling. J Biol Chem 290:100-104.